184 related articles for article (PubMed ID: 24650966)
1. In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms.
Rebours V; Le Faouder J; Laouirem S; Mebarki M; Albuquerque M; Camadro JM; Léger T; Ruszniewski P; Lévy P; Paradis V; Bedossa P; Couvelard A
Pancreatology; 2014; 14(2):117-24. PubMed ID: 24650966
[TBL] [Abstract][Full Text] [Related]
2. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
3. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas.
Corcos O; Couvelard A; Dargère D; Sauvanet A; Hammel P; Paradis V; Lévy P; Ruszniewski P; Bedossa P
Pancreas; 2012 Mar; 41(2):169-74. PubMed ID: 22076567
[TBL] [Abstract][Full Text] [Related]
4. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy.
Maire F; Voitot H; Aubert A; Palazzo L; O'Toole D; Couvelard A; Levy P; Vidaud M; Sauvanet A; Ruszniewski P; Hammel P
Am J Gastroenterol; 2008 Nov; 103(11):2871-7. PubMed ID: 18775021
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases.
Salla C; Chatzipantelis P; Konstantinou P; Karoumpalis I; Sakellariou S; Pantazopoulou A; Manika Z
JOP; 2007 Nov; 8(6):715-24. PubMed ID: 17993724
[TBL] [Abstract][Full Text] [Related]
6. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.
Grüner BM; Hahne H; Mazur PK; Trajkovic-Arsic M; Maier S; Esposito I; Kalideris E; Michalski CW; Kleeff J; Rauser S; Schmid RM; Küster B; Walch A; Siveke JT
PLoS One; 2012; 7(6):e39424. PubMed ID: 22761793
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: the PIPE Study.
Yoon WJ; Daglilar ES; Fernández-del Castillo C; Mino-Kenudson M; Pitman MB; Brugge WR
Endoscopy; 2014 May; 46(5):382-7. PubMed ID: 24619804
[TBL] [Abstract][Full Text] [Related]
8. AKR1B10 expression by immunohistochemistry in surgical resections and fine needle aspiration cytology material in patients with cystic pancreatic lesions; potential for improved nonoperative diagnosis.
Connor JP; Esbona K; Matkowskyj KA
Hum Pathol; 2017 Dec; 70():77-83. PubMed ID: 29079172
[TBL] [Abstract][Full Text] [Related]
9. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas.
Kobayashi N; Sugimori K; Shimamura T; Hosono K; Watanabe S; Kato S; Ueda M; Endo I; Inayama Y; Maeda S; Nakajima A; Kubota K
Pancreatology; 2012; 12(2):141-5. PubMed ID: 22487524
[TBL] [Abstract][Full Text] [Related]
11. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor α levels in pancreatic fluid.
Doyle CJ; Agaram NP; Yip-Schneider MT; Schmidt CM
Pancreas; 2011 Mar; 40(2):260-4. PubMed ID: 21404459
[TBL] [Abstract][Full Text] [Related]
13. MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions.
Maccarrone G; Nischwitz S; Deininger SO; Hornung J; König FB; Stadelmann C; Turck CW; Weber F
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1047():131-140. PubMed ID: 27461358
[TBL] [Abstract][Full Text] [Related]
14. MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer.
Gemoll T; Strohkamp S; Schillo K; Thorns C; Habermann JK
Oncotarget; 2015 Dec; 6(41):43869-80. PubMed ID: 26556858
[TBL] [Abstract][Full Text] [Related]
15. Biomarker Development for Intraductal Papillary Mucinous Neoplasms Using Multiple Reaction Monitoring Mass Spectrometry.
Kim Y; Kang M; Han D; Kim H; Lee K; Kim SW; Kim Y; Park T; Jang JY; Kim Y
J Proteome Res; 2016 Jan; 15(1):100-13. PubMed ID: 26561977
[TBL] [Abstract][Full Text] [Related]
16. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas.
Khannoussi W; Vullierme MP; Rebours V; Maire F; Hentic O; Aubert A; Sauvanet A; Dokmak S; Couvelard A; Hammel P; Ruszniewski P; Lévy P
Pancreatology; 2012; 12(3):198-202. PubMed ID: 22687372
[TBL] [Abstract][Full Text] [Related]
17. Gene expression changes associated with the progression of intraductal papillary mucinous neoplasms.
Jury RP; Thibodeau BJ; Fortier LE; Geddes TJ; Ahmed S; Pruetz BL; Farinola MA; Wilson GD
Pancreas; 2012 May; 41(4):611-8. PubMed ID: 22273699
[TBL] [Abstract][Full Text] [Related]
18. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
Tanaka M
Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2.
Nakahara O; Takamori H; Iwatsuki M; Baba Y; Sakamoto Y; Tanaka H; Chikamoto A; Horino K; Beppu T; Kanemitsu K; Honda Y; Iyama K; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S565-71. PubMed ID: 21932133
[TBL] [Abstract][Full Text] [Related]
20. Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms.
Chhoda A; Sharma A; Sailo B; Tang H; Ruzgar N; Tan WY; Ying L; Khatri R; Narayanan A; Mane S; De Kumar B; Wood LD; Iacobuzio-Donahue C; Wolfgang CL; Kunstman JW; Salem RR; Farrell JJ; Ahuja N
Clin Epigenetics; 2023 Feb; 15(1):28. PubMed ID: 36803844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
